Malaysia Foundation Developing Targeted Cancer Drugs 10 Years On
This article was originally published in PharmAsia News
A Malaysia foundation is developing targeted cancer drugs and plans to train more researchers to understand the disease.
You may also be interested in...
A collaboration between Novo and Fauna will look at animal hibernation and genetic sequencing for hints toward novel therapies for obesity. Pfizer will use Insilico’s machine learning technology in target validation.